Robbie Marcus
Stock Analyst at JP Morgan
(3.95)
# 578
Out of 5,123 analysts
177
Total ratings
56.03%
Success rate
9.06%
Average return
Main Sectors:
Stocks Rated by Robbie Marcus
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EW Edwards Lifesciences | Upgrades: Overweight | $90 → $100 | $78.01 | +28.19% | 7 | Dec 18, 2025 | |
| INSP Inspire Medical Systems | Maintains: Neutral | $82 → $118 | $67.07 | +75.94% | 8 | Dec 16, 2025 | |
| COO The Cooper Companies | Maintains: Neutral | $66 → $78 | $80.53 | -3.14% | 7 | Dec 5, 2025 | |
| MDT Medtronic | Maintains: Neutral | $90 → $100 | $104.03 | -3.87% | 12 | Nov 13, 2025 | |
| HTFL HeartFlow | Maintains: Overweight | $36 → $40 | $27.05 | +47.87% | 2 | Nov 13, 2025 | |
| CNMD CONMED | Maintains: Neutral | $58 → $52 | $40.31 | +29.00% | 8 | Nov 6, 2025 | |
| RXST RxSight | Maintains: Underweight | $8 → $9 | $7.84 | +14.80% | 6 | Nov 6, 2025 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Neutral | $115 → $100 | $88.39 | +13.13% | 7 | Nov 6, 2025 | |
| CBLL CeriBell | Maintains: Overweight | $21 → $17 | $19.82 | -14.23% | 2 | Nov 5, 2025 | |
| DXCM DexCom | Maintains: Neutral | $90 → $75 | $70.34 | +6.62% | 3 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $12 → $13 | $11.05 | +17.65% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $16 | $16.58 | -3.47% | 3 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $14 → $16 | $16.01 | -0.06% | 5 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $15 → $7 | $6.74 | +3.86% | 7 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $120 | $80.04 | +49.93% | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $38 → $36 | $21.56 | +66.98% | 17 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $420 → $445 | $362.24 | +22.85% | 9 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $575 → $675 | $479.70 | +40.71% | 5 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $12 → $13 | $8.26 | +57.31% | 3 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $110 | $78.51 | +40.11% | 13 | Dec 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $280 → $330 | $244.81 | +34.80% | 4 | Dec 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $30 → $40 | $37.07 | +7.92% | 5 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $90 | $82.63 | +8.92% | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $53 → $50 | $22.26 | +124.62% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $8 | $2.09 | +282.78% | 2 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $284 → $250 | $343.13 | -27.14% | 9 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $7 | $5.74 | +21.95% | 13 | Nov 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $125 → $118 | $108.94 | +8.32% | 5 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $116 → $156 | $149.70 | +4.21% | 2 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $40 | $114.99 | -65.21% | 2 | May 5, 2020 |
Edwards Lifesciences
Dec 18, 2025
Upgrades: Overweight
Price Target: $90 → $100
Current: $78.01
Upside: +28.19%
Inspire Medical Systems
Dec 16, 2025
Maintains: Neutral
Price Target: $82 → $118
Current: $67.07
Upside: +75.94%
The Cooper Companies
Dec 5, 2025
Maintains: Neutral
Price Target: $66 → $78
Current: $80.53
Upside: -3.14%
Medtronic
Nov 13, 2025
Maintains: Neutral
Price Target: $90 → $100
Current: $104.03
Upside: -3.87%
HeartFlow
Nov 13, 2025
Maintains: Overweight
Price Target: $36 → $40
Current: $27.05
Upside: +47.87%
CONMED
Nov 6, 2025
Maintains: Neutral
Price Target: $58 → $52
Current: $40.31
Upside: +29.00%
RxSight
Nov 6, 2025
Maintains: Underweight
Price Target: $8 → $9
Current: $7.84
Upside: +14.80%
Zimmer Biomet Holdings
Nov 6, 2025
Downgrades: Neutral
Price Target: $115 → $100
Current: $88.39
Upside: +13.13%
CeriBell
Nov 5, 2025
Maintains: Overweight
Price Target: $21 → $17
Current: $19.82
Upside: -14.23%
DexCom
Oct 31, 2025
Maintains: Neutral
Price Target: $90 → $75
Current: $70.34
Upside: +6.62%
Oct 31, 2025
Maintains: Underweight
Price Target: $12 → $13
Current: $11.05
Upside: +17.65%
Oct 30, 2025
Maintains: Neutral
Price Target: $13 → $16
Current: $16.58
Upside: -3.47%
May 14, 2025
Maintains: Overweight
Price Target: $14 → $16
Current: $16.01
Upside: -0.06%
May 9, 2025
Downgrades: Underweight
Price Target: $15 → $7
Current: $6.74
Upside: +3.86%
Mar 28, 2025
Initiates: Overweight
Price Target: $120
Current: $80.04
Upside: +49.93%
Feb 21, 2025
Maintains: Neutral
Price Target: $38 → $36
Current: $21.56
Upside: +66.98%
Jan 29, 2025
Maintains: Overweight
Price Target: $420 → $445
Current: $362.24
Upside: +22.85%
Jan 24, 2025
Maintains: Overweight
Price Target: $575 → $675
Current: $479.70
Upside: +40.71%
Dec 17, 2024
Upgrades: Neutral
Price Target: $12 → $13
Current: $8.26
Upside: +57.31%
Dec 16, 2024
Maintains: Overweight
Price Target: $100 → $110
Current: $78.51
Upside: +40.11%
Dec 12, 2024
Maintains: Overweight
Price Target: $280 → $330
Current: $244.81
Upside: +34.80%
Oct 30, 2024
Maintains: Overweight
Price Target: $30 → $40
Current: $37.07
Upside: +7.92%
Sep 9, 2024
Initiates: Neutral
Price Target: $90
Current: $82.63
Upside: +8.92%
Aug 8, 2024
Maintains: Neutral
Price Target: $53 → $50
Current: $22.26
Upside: +124.62%
May 8, 2024
Downgrades: Neutral
Price Target: $15 → $8
Current: $2.09
Upside: +282.78%
Feb 23, 2024
Downgrades: Neutral
Price Target: $284 → $250
Current: $343.13
Upside: -27.14%
Nov 8, 2023
Maintains: Underweight
Price Target: $8 → $7
Current: $5.74
Upside: +21.95%
Oct 20, 2022
Maintains: Overweight
Price Target: $125 → $118
Current: $108.94
Upside: +8.32%
Jan 27, 2022
Maintains: Overweight
Price Target: $116 → $156
Current: $149.70
Upside: +4.21%
May 5, 2020
Maintains: Neutral
Price Target: $55 → $40
Current: $114.99
Upside: -65.21%